NCT00068393 2023-07-07Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell CarcinomaEastern Cooperative Oncology GroupPhase 2 Completed39 enrolled 7 charts
NCT02650635 2018-09-05TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsMayo ClinicPhase 1 Terminated4 enrolled